NYSE:LLY

Eli Lilly Stock Insider Trading

Healthcare > Drug Manufacturers - General

Buy LLY

*Your capital is at risk

$1,083.23

+18.39 (+1.73%)

At Close: Jun 03, 2026

Eli Lilly Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -72.92. In total, the insiders bought 24.59M and sold 316.01M LLY shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-72.92
● Buy	24.59M shares
● Sell	316.01M shares
61% Buy Activity Moderate Negative Correlation
Sell Signal High Confidence Nov 14, 2025 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -72.92. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 01, 2026 Buy	Restricted Stock Unit M-Exempt	Van Naarden Jacob EVP,pres Lly Oncology&hdcorpbd	Officer	4 108 Value: $4.45M
Feb 01, 2026 Sell	Common Stock F-InKind	Ricks David A President, Chair, And CEO	CEO / President	14 297 Value: $14.8M
Feb 01, 2026 Sell	Common Stock F-InKind	Jonsson Patrik EVP & President, Lly Int'l	CEO / President	1 752 Value: $1.82M
Feb 01, 2026 Buy	Restricted Stock Unit M-Exempt	Ricks David A President, Chair, And CEO	CEO / President	31 932 Value: $34.6M
Feb 01, 2026 Buy	Common Stock M-Exempt	Ricks David A President, Chair, And CEO	CEO / President	31 932 Value: $34.6M
Feb 01, 2026 Buy	Restricted Stock Unit M-Exempt	Dozier Eric EVP, Chief People Officer	Officer	2 858 Value: $3.10M
Feb 01, 2026 Sell	Common Stock F-InKind	Rau Diogo EVP & Cido	Officer	1 674 Value: $1.74M
Feb 01, 2026 Buy	Common Stock M-Exempt	Dozier Eric EVP, Chief People Officer	Officer	2 858 Value: $3.10M
Feb 01, 2026 Buy	Restricted Stock Unit M-Exempt	Rau Diogo EVP & Cido	Officer	3 752 Value: $4.06M
Feb 01, 2026 Buy	Common Stock M-Exempt	Jonsson Patrik EVP & President, Lly Int'l	CEO / President	3 930 Value: $4.26M
Feb 01, 2026 Buy	Restricted Stock Unit M-Exempt	Jonsson Patrik EVP & President, Lly Int'l	CEO / President	3 930 Value: $4.26M
Feb 01, 2026 Buy	Restricted Stock Unit M-Exempt	Skovronsky Daniel EVP, Cs&po & Pres. Lrl	Officer	12 684 Value: $13.7M
Feb 01, 2026 Buy	Common Stock M-Exempt	Van Naarden Jacob EVP,pres Lly Oncology&hdcorpbd	Officer	4 108 Value: $4.45M
Feb 01, 2026 Buy	Common Stock M-Exempt	Skovronsky Daniel EVP, Cs&po & Pres. Lrl	Officer	12 684 Value: $13.7M
Feb 01, 2026 Sell	Common Stock F-InKind	Skovronsky Daniel EVP, Cs&po & Pres. Lrl	Officer	5 641 Value: $5.85M
Feb 01, 2026 Buy	Common Stock M-Exempt	Hernandez Edgardo EVP & Pres., Mfg. Operations	Officer	3 572 Value: $3.87M
Feb 01, 2026 Sell	Common Stock F-InKind	Hernandez Edgardo EVP & Pres., Mfg. Operations	Officer	1 591 Value: $1.65M
Feb 01, 2026 Buy	Restricted Stock Unit M-Exempt	Hernandez Edgardo EVP & Pres., Mfg. Operations	Officer	3 572 Value: $3.87M
Feb 01, 2026 Buy	Common Stock M-Exempt	Hakim Anat EVP, GC & Secretary	Officer	6 700 Value: $7.26M
Feb 01, 2026 Sell	Common Stock F-InKind	Hakim Anat EVP, GC & Secretary	Officer	2 953 Value: $3.06M
Feb 01, 2026 Buy	Common Stock M-Exempt	Yuffa Ilya EVP&pres, Lly Usa&global Capab	Officer	3 394 Value: $3.68M
Feb 01, 2026 Sell	Common Stock F-InKind	Yuffa Ilya EVP&pres, Lly Usa&global Capab	Officer	1 512 Value: $1.57M
Feb 01, 2026 Buy	Restricted Stock Unit M-Exempt	Yuffa Ilya EVP&pres, Lly Usa&global Capab	Officer	3 394 Value: $3.68M
Jan 20, 2026 Buy	Common Stock A-Award	Alvarez Ralph Director	Director	12 Value: $12.4K
Jan 20, 2026 Buy	Common Stock A-Award	Luciano Juan R Director	Director	15 Value: $15.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ELI LILLY AND COMPANY

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer ...

Read Full Profile Here